Drug Profile
NMP 0165
Alternative Names: NM 10165Latest Information Update: 11 Feb 2008
Price :
$50
*
At a glance
- Originator NexMed
- Class Urologics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Overactive bladder
Most Recent Events
- 17 Jul 2003 Preclinical trials in Overactive bladder in USA (Transdermal)